Elucidating Novel Targets for Ovarian Cancer Antibody–Drug Conjugate Development: Integrating In Silico Prediction and Surface Plasmon Resonance to Identify Targets with Enhanced Antibody Internalization Capacity
- DOI
- 10.3390/antib12040065
- Published
- 2023-10-16
- Container
- Antibodies
- Publisher
- MDPI AG
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3390/antib12040065,
title = {Elucidating Novel Targets for Ovarian Cancer Antibody–Drug Conjugate Development: Integrating In Silico Prediction and Surface Plasmon Resonance to Identify Targets with Enhanced Antibody Internalization Capacity},
author = {Emenike Kenechi Onyido and David James and Jezabel Garcia-Parra and John Sinfield and Anna Moberg and Zoe Coombes and Jenny Worthington and Nicole Williams and Lewis Webb Francis and Robert Steven Conlan and Deyarina Gonzalez},
year = {2023},
journal = {Antibodies},
doi = {10.3390/antib12040065},
url = {https://doi.org/10.3390/antib12040065}
}RIS
TY - JOUR TI - Elucidating Novel Targets for Ovarian Cancer Antibody–Drug Conjugate Development: Integrating In Silico Prediction and Surface Plasmon Resonance to Identify Targets with Enhanced Antibody Internalization Capacity AU - Emenike Kenechi Onyido AU - David James AU - Jezabel Garcia-Parra AU - John Sinfield AU - Anna Moberg AU - Zoe Coombes AU - Jenny Worthington AU - Nicole Williams AU - Lewis Webb Francis AU - Robert Steven Conlan AU - Deyarina Gonzalez PY - 2023 JO - Antibodies DO - 10.3390/antib12040065 UR - https://doi.org/10.3390/antib12040065 ER -
APA
Onyido, E. K., James, D., Garcia-Parra, J., Sinfield, J., Moberg, A., Coombes, Z., Worthington, J., Williams, N., Francis, L. W., Conlan, R. S., & Gonzalez, D. (2023). Elucidating Novel Targets for Ovarian Cancer Antibody–Drug Conjugate Development: Integrating In Silico Prediction and Surface Plasmon Resonance to Identify Targets with Enhanced Antibody Internalization Capacity. Antibodies. https://doi.org/10.3390/antib12040065
Source records
- crossref · retrieved 2026-09-26T08:31:55.151Z